rs139753431
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_033305.3(VPS13A):āc.7053T>Cā(p.Ala2351Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,609,510 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0058 ( 12 hom., cov: 32)
Exomes š: 0.00062 ( 14 hom. )
Consequence
VPS13A
NM_033305.3 synonymous
NM_033305.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.639
Genes affected
VPS13A (HGNC:1908): (vacuolar protein sorting 13 homolog A) The protein encoded by this gene may control steps in the cycling of proteins through the trans-Golgi network to endosomes, lysosomes and the plasma membrane. Mutations in this gene cause the autosomal recessive disorder, chorea-acanthocytosis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 9-77344179-T-C is Benign according to our data. Variant chr9-77344179-T-C is described in ClinVar as [Benign]. Clinvar id is 448870.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-77344179-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.639 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00575 (876/152248) while in subpopulation AFR AF= 0.0203 (845/41558). AF 95% confidence interval is 0.0192. There are 12 homozygotes in gnomad4. There are 408 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 12 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS13A | NM_033305.3 | c.7053T>C | p.Ala2351Ala | synonymous_variant | 51/72 | ENST00000360280.8 | NP_150648.2 | |
VPS13A | NM_001018037.2 | c.6936T>C | p.Ala2312Ala | synonymous_variant | 50/71 | NP_001018047.1 | ||
VPS13A | NM_015186.4 | c.7053T>C | p.Ala2351Ala | synonymous_variant | 51/69 | NP_056001.1 | ||
VPS13A | NM_001018038.3 | c.7053T>C | p.Ala2351Ala | synonymous_variant | 51/69 | NP_001018048.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS13A | ENST00000360280.8 | c.7053T>C | p.Ala2351Ala | synonymous_variant | 51/72 | 1 | NM_033305.3 | ENSP00000353422.3 | ||
VPS13A | ENST00000376636.7 | c.6936T>C | p.Ala2312Ala | synonymous_variant | 50/71 | 1 | ENSP00000365823.3 | |||
VPS13A | ENST00000643348.1 | c.7053T>C | p.Ala2351Ala | synonymous_variant | 51/69 | ENSP00000493592.1 | ||||
VPS13A | ENST00000645632.1 | c.7053T>C | p.Ala2351Ala | synonymous_variant | 51/69 | ENSP00000496361.1 |
Frequencies
GnomAD3 genomes AF: 0.00574 AC: 873AN: 152130Hom.: 12 Cov.: 32
GnomAD3 genomes
AF:
AC:
873
AN:
152130
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00156 AC: 393AN: 251326Hom.: 6 AF XY: 0.00110 AC XY: 149AN XY: 135870
GnomAD3 exomes
AF:
AC:
393
AN:
251326
Hom.:
AF XY:
AC XY:
149
AN XY:
135870
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000620 AC: 904AN: 1457262Hom.: 14 Cov.: 30 AF XY: 0.000567 AC XY: 411AN XY: 725260
GnomAD4 exome
AF:
AC:
904
AN:
1457262
Hom.:
Cov.:
30
AF XY:
AC XY:
411
AN XY:
725260
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00575 AC: 876AN: 152248Hom.: 12 Cov.: 32 AF XY: 0.00548 AC XY: 408AN XY: 74450
GnomAD4 genome
AF:
AC:
876
AN:
152248
Hom.:
Cov.:
32
AF XY:
AC XY:
408
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3472
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 07, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 18, 2018 | - - |
Chorea-acanthocytosis Benign:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at